简介：AbstractImportance:There is a high incidence of iron deficiency in children worldwide. Notably, however, while iron deficiency is the most common cause of anemia, little is known about the prevalence and different types of iron deficiency in neuroblastoma patients.Objective:The aim of the present study was to investigate the prevalence of iron deficiency in patients newly diagnosed with neuroblastoma.Methods:A total of 195 newly diagnosed neuroblastoma patients from November 2015 to January 2018 were analyzed retrospectively. The survival analysis was estimated by the Kaplan-Meier method.Results:Of the 195 neuroblastoma patients included in the study, 121 (62.1%) had iron deficiency, 55 (28.2%) had absolute iron deficiency, and 66 (33.9%) had functional iron deficiency. Being aged ≥ 18 months, tumor originating in the abdomen, International Neuroblastoma Risk Group Staging System M, high-risk neuroblastoma, lactate dehydrogenase ≥ 1500 U/L, neuron-specific enolase ≥ 100 U/L, unfavorable histologic category, MYCN amplification, chromosome 1p loss, and bone marrow metastasis were associated with significantly higher rates of functional iron deficiency (P < 0.05).Interpretation:Functional iron deficiency at the time of initial neuroblastoma diagnosis predicted lower event-free survival. Long-term effects of iron supplementation in neuroblastoma patients with different types of iron deficiency need to be further studied.

简介：Simulatingbiologicalolfactoryneuralsystem,KⅢnetwork,whichisahigh-dimensionalchaoticneuralnetwork,isdesignedinthispaper.Differentfromconventionalartificialneuralnetwork,theKⅢnetworkworksinitschaotictrajectory.ItcansimulatenotonlytheoutputEEGwaveformobservedinelectrophysiologicalexperiments,butalsothebiologicalintelligenceforpatternclassification.Thesimulationanalysisandapplicationtotherecognitionofhandwritingnmeralsarepresentedhere.TheclassificationperformanceoftheKⅢnetworkatdifferentnoiselevelswasalsoinvestigated.

简介：

简介：

简介：AbstractPatients with aspirin exacerbated respiratory disease (AERD) experience a severe and recalcitrant form of chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma, which are exacerbated by aspirin/NSAID ingestion. As compared with aspirin-tolerant CRSwNP, patients with AERD experience more severe olfactory dysfunction, which is one of the key contributors to the observed decrease in quality of life (QOL) in this disease. The objective of this paper is to review the published olfactory outcomes observed with various treatment modalities.

简介：AbstractImportance:Irradiation treatment for pediatric patients with neuroblastoma represents a major challenge due to the pediatric dose limits for critical structures and the necessity of sufficient dose coverage of the clinical target volume for local control.Objective:To investigate dosimetric differences between tomotherapy (TOMO) and volumetric-modulated arc therapy (VMAT) as retroperitoneal radiotherapy for children with neuroblastoma.Methods:Eight patients who received retroperitoneal radiotherapy for neuroblastoma were selected for comparison of TOMO and VMAT treatment plans. The Dmin, Dmax, Dmean, D95, D2, and D98 of planning target volume (PTV), conformity index (CI), heterogeneity index (HI), and organs at risk (OARs) parameters were compared. Delivery machine unit (MU) and image-guide radiotherapy solution results were also compared.Results:All patients received a cumulative dose of 19.5 Gy to the PTV. VMAT showed higher CI (0.93 ± 0.02), compared with TOMO (0.87 ± 0.03, P < 0.001). Notably, the average PTV HI was significantly better using TOMO (1.05 ± 0.01) than VMAT (1.08 ± 0.02, P = 0.003). Compared with VMAT, the Dmin, D95, and D98 all exhibited increases in TOMO; Dmax variation was less than 1% in TOMO. The D0.1cc for the spinal cord and D2cc for the small intestine were better in TOMO in terms of OARs. However, TOMO had more MUs and required a longer delivery time.Interpretation:Both planning techniques are capable of producing high-quality treatment plans. TOMO is superior for PTV coverage, but inferior for CI. TOMO requires extra treatment time; its cost is greater than the cost of VMAT.

简介：嗅觉的ensheathing房间(OEC)是有axonal的glial房间的一种唯一的类型支持生长的性质。OEC移植作为axonal损害和demyelinating疾病的有希望的试验性的治疗出现了。然而，OEC的一些基本细胞的性质仍然保持不清楚。在这研究，我们发现不同OEC候补选手人口基于单个孤立的房间的微速摄影的成像展出了不同迁移的性质，可能由于他们的不同细胞骨架组织。而且，OEC潜水艇人口在单个房间的迁居试金显示了不同吸引人的迁移的回答到lysophosphatidic酸(LPA)的一个坡度。最后，我们发现了人口自发地转变了成对方的那个OEC代用品。一起，这些结果示威，第一次到我们的知识，不同OEC潜水艇人口显示不同迁移的性质试管内并且提供新证据当一个单个房间与韧性的功能的显型打字，支持OEC的观点。

简介：AbstractImportance:Neuroblastoma is the most common extracranial malignant solid tumor in children. Multidisciplinary care is critical to improving the survival of pediatric patients with neuroblastoma.Objective:To systematically summarize the clinical characteristics of children with neuroblastoma and evaluate their prognosis with multidisciplinary care provided in a single center.Methods:This retrospective study analyzed the clinical data of 1041 patients with neuroblastoma who were diagnosed, treated, and followed-up in the Hematology-Oncology Center of Beijing Children’s Hospital from 2007 to 2019.Results:The median age at diagnosis was 34 months; 80.8% of the patients were younger than 5 years of age. Notably, 243 patients (23.3%) were classified as low-risk, 249 patients (23.9%) were classified as intermediate-risk, and 549 (52.7%) were classified as high-risk. Furthermore, 956 patients underwent surgical resections; 986 (94.7%) patients received chemotherapy; and 176 patients with high-risk neuroblastoma received hematopoietic stem cell transplantation. The 5-year event-free survival (EFS) rate was 91.3% and 5-year overall survival (OS) rate was 97.5% in low-risk group; in the intermediate-risk group, these rates were 85.1% and 96.7%, respectively, while they were 37.7% and 48.9% in the high-risk group (P < 0.001 for both). The 5-year EFS and OS rates were significantly higher in patients diagnosed between 2015 and 2019 than in patients diagnosed between 2007 and 2014 (P < 0.001). In total, 278 patients (26.7%) exhibited tumor relapse or progression; the median interval until relapse or progression was 14 months. Of the 233 patients who died, 83% died of relapse or progression of neuroblastoma and 4.3% died of therapy-related complications.Interpretation:The 5-year OS rate was low in high-risk patients, compared with low-and intermediate-risk patients. Multidisciplinary care is critical for improvement of survival in pediatric patients with neuroblastoma. Additional treatment strategies should be sought to improve the prognosis of patients with high-risk neuroblastoma.

简介：Objective:Toobservetheeffectsofcryopreservedolfactoryensheathingcells(OECs)transplantationonaxonalregenerationandfunctionalrecoveryfollowingspinalcordinjuryinadultrats.Methods:Twenty-fourratsweredividedintoexperimentalandcontrolgroups,eachgrouphaving12rats.ThespinalcordinjurywasestablishedbytransectingthespinalcordatT10levelwithmicrosurgeryscissors.OECswerepurifiedfromSDratolfactorybulbandculturedinDMEM(Dulbecco'sminimumessentialmedium)andcryopreserved(-120℃)fortwoweeks.OECssuspension[(1-1.4)×105/ul]wastransplantedintotransectedspinalcord,whiletheDMEMsolutionwasinjectedinsteadinthecontrolgroup.At6and12weeksaftertransplantation,theratswereevaluatedwithclimbingtestandMEP(moterevokedpotentials)monitoring.Thesamplesofspinalcordwereprocuredandstudiedwithhistologicalandimmunohistochemicalstainings.Results:At6weeksaftertransplantation,alloftheratsinbothtransplantedandcontrolgroupswereparaplegic,andMEPscouldnotberecorded.MorphologyoftransplantedOECswasnormal,andOECswereinterfusedwithhostwell.Axonscouldregrowintogaptissuebetweenthespinalcords.BothOECsandregrownaxonswereimmunoreactiveforMBP.Noregrownaxonswerefoundinthecontrolgroup.At12weeksaftertransplantation,2rats(2/7)hadlowerextremitiesmusclecontraction,2rats(2/7)hadhipand/orkneeactivemovement,andMEPof5rats(5/7)couldberecordedinthecalfinthetransplantationgroup.Noneoftherats(7/7)inthecontrolgrouphadfunctionalimprovement,andnonehadMEPsrecorded.Inthetransplantedgroup,histologicalandimmunohistochemicalmethodsshowedthenumberoftransplantedOECsreducedandsomeregrownaxonshadreachedtheendoftransectedspinalcord.However,noregrownaxonscouldbeseenexceptscarformationinthecontrolgroup.Conclusions:CryopreservedOECscouldintegratedwiththehostandpromoteregrowingaxonsacrossthetransectedsp

简介：Forty-threepatientswithchronicspinalcordinjuryforover6monthsweretransplantedwithembryonicolfactoryensheathingcells,2–4×106,intomultiplesitesintheinjuredareaunderthesurgicalmicroscope.Thesympatheticskinresponseinpatientswasmeasuredwithanelectromyography/evokedpotentialinstrument1daybeforetransplantationand3–8weeksaftertransplantation.SpinalnervefunctionofpatientswasassessedusingtheAmericanSpinalInjuryAssociationimpairmentscale.Thesympatheticskinresponsewaselicitedin32casesbeforeolfactoryensheathingcelltransplantation,whileitwasobservedin34casesaftertransplantation.Concomitantly,sympatheticskinresponselatencydecreasedsignificantlyandamplitudeincreasedsignificantlyaftertransplantation.TransplantationofolfactoryensheathingcellsalsoimprovedAmericanSpinalInjuryAssociationscoresformovement,painandlighttouch.Ourfindingsindicatethatolfactoryensheathingcelltransplantationimprovesmotor,sensoryandautonomicnervefunctionsinpatientswithchronicspinalcordinjury.

简介：Atpresent,thereisnoeffectivetreatmentfortherepairoftheopticnerveafterinjury,orimprovementofitsmicroenvironmentforregeneration.Intravitreallyinjectedciliaryneurotrophicfactor(CNTF)andolfactoryensheathingcells(OECs)promotethelong-distanceregrowthofseveredopticnervefibersafterintracranialinjury.Here,weexaminedtheefficacyofthesetechniquesaloneandincombination,inaratmodelofopticnerveinjury.WeinjectedcondensedOECsuspensionatthesiteofinjury,orCNTFintothevitreousbody,orbothsimultaneously.Retrogradetracingtechniquesshowedthat4weekspostoperatively,thenumberofsurvivingretinalganglioncellsandtheiraxonaldensityintheopticnerveweregreaterinratssubjectedtoOECinjectiononlythaninthosereceivingCNTFinjectiononly.Furthermore,combinedOEC+CNTFinjectionachievedbetterresultsthaneithermonotherapy.ThesefindingsconfirmthatOECsarebetterthanCNTFatprotectinginjuredneuronsintheeye,butthatcombinedOECandCNTFtherapyisnotablymoreeffectivethaneithertreatmentalone.

简介：

简介：Inthepresentstudyexpressionofestrogenreceptorsubtype-α(ERα)and-β(ERβ)inthecerebralcortex,cerebellum,andolfactorybulbwasinvestigatedandcomparedbetweenneonatal(1～3-days-old)andadult(250～350g)rats,usingreversetranscription-polymerasechainreaction(RT-PCR).NoERαtranscriptsweredetectableintheadultcerebellumandolfactorybulb,whereasveryweakexpressionofERαwaspresentintheadultcerebralcortex.NosignificantdifferenceinERβtranscriptswasdetectablebetweentheneonatalandadultrats.WhiletranscriptsforbothERsubtypeswereco-expressedinthesebrainareasofneonatalrats,althoughERαexpressionwassignificantlyweakerthanERβ.EveninthecerebralcortexknowntocontainbothERsubtypesinadultrats,ERαtranscriptsinneonatalratsweremuchhigherthaninadult.TheseobservationsprovideevidencefortheexistenceofdifferentexpressionpatternsofERα/ERβtranscriptsinthesethreebrainareasbetweentheneonatalandadultrats,suggestingthateachERsubtypemayplayadistinctroleintheregulationofdifferentiation,development,andfunctionsofthebrainbyestrogen.

简介：BACKGROUND:Olfactoryensheathingcelltransplantationcanactivateaxonalregenerationandenhancemyelinrepair,whicharebeneficialfortreatingdemyelinatingdiseases.OBJECTIVE:Toexploretheeffectsofolfactoryensheathingcelltransplantationonmyelinrepair,synaptophysinexpression,andmotorfunctioninaratmodelofexperimentalallergicencephalomyelitis.DESIGN,TIMEANDSETTING:Arandomized,controlledexperimentwasperformedattheLaboratoryofProvincialHospitalaffiliatedtoShandongUniversitybetweenAugust2006andSeptember2007.MATERIALS:Dibenzylamine(Hoechst33342),luxolfastblue,andrabbitanti-ratsynaptophysinantibodywereprovidedbySigma,USA.METHODS:OlfactoryensheathingcellsextractedfromneonatalWistarratswereculturedfor10-14daysandlabeledwithdibenzylamine.SpinalcordextractedfromahealthyguineapigwashomogenizedandequallymixedwithcompleteFreund'sadjuvant;thereafter,themixturewasintracutaneouslyinjectedintotwoposteriorvoixpedisofhealthymaleWistarratstoestablishmodelsofexperimentalallergicencephalomyelitis.Ratswererandomlydividedintoacontrolencephalomyelitisgroupandanolfactoryensheathingcelltransplantationgroup,36ratsineachgroup.Physiologicalsaline(2μL)oranolfactoryensheathingcellsuspension(2μL)wasseparatelyinjectedalonglateralcerebralventricleatday7post-modelinduction.MAINOUTCOMEMEASURES:Themigrationanddistributionofolfactoryensheathingcellswereobservedunderfluorescencemicroscopy;myelinrepairwasdetectedusinghematoxylin-eosinstainingandluxolfastbluestaining;synaptophysinexpressionwasmeasuredusingimmunohistochemicalstaining;motorfunctionwasevaluatedusingamotorfunctionscale.RESULTS:Olfactoryensheathingcellscouldsurviveinvivoandmigratetothedistalendofthetransplantfocusandspinalcord,andsurvived21days.Hematoxylin-eosinstainingandluxolfastbluestainingindicatedthatmyelininthetransplantationgroupwasintact,andtheinfla

简介：Theactiveingredientofginseng,ginsenosidesRg1,hasbeenshowntoscavengefreeradicalsandimproveantioxidantcapacity.ThisstudyhypothesizedthatginsenosidesRg1hasaprotectiveroleinhumanneuroblastomacellsinjuredbyH_2O_2.GinsenosidesRg1atdifferentconcentrations(50and100μM)wasusedtotreatH_2O_2(150μM)-injuredSH-SY5Ycells.ResultsdemonstratedthatginsenosideRg1elevatedthesurvivalrateofSH-SY5YcellsinjuredbyH_2O_2,diminishedtheamountofleakedlactatedehydrogenase,andincreasedsuperoxidedismutaseactivity.GinsenosideRg1effectivelysuppressedcaspase-3immunoreactivity,andcontributedtoheatshockprotein70geneexpression,inadose-dependentmanner.TheseresultsindicatethatginsenosideRg1hasprotectiveeffectsonSH-SY5YcellsinjuredbyH_2O_2andthatitsmechanismofactionisassociatedwithanti-oxidationandtheinhibitionofapoptosis.

简介：AbstractBackground:Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. It has been demonstrated that microRNA-145 (miR-145) is correlated with the progression of various cancers by regulating the expression of multiple target genes, especially a number of genes that regulate angiogenesis and proliferation. However, the underlying mechanisms of miR-145 in tumor angiogenesis of UM are still not well illustrated. Thus, we aimed to explore the potential target genes or pathways regulated by miR-145 in UM and the effect of miR-145 on invasion and angiogenesis.Methods:Totally, 24 choroid samples were collected in our study, including 12 UM samples and 12 normal uveal tissues. The expression of neuroblastoma RAS viral oncogene homolog (N-RAS), phosphorylated protein kinase B (p-AKT), and vascular endothelial growth factor (VEGF) in UM tissues and normal uveal tissues was analyzed using Western blotting analysis. Lentivirus expression system was used to construct MUM-2B and OCM-1 cell lines with stable overexpression of miR-145. Transwell and endothelial cell tube formation assay were used to measure the effects of miR-145 on the invasion and angiogenesis of UM in vitro. The downstream target genes of miR-145 were predicted by bioinformatics and confirmed using a luciferase assay. BALB/c nude mice models were established to investigate the mechanisms of miR-145 on tumor growth and angiogenesis in vivo. Group data comparisons were performed using analysis of Student’s t test. A two-tailed P < 0.05 was considered as statistically significant.Results:The results of Western blotting analysis indicated that the expressions of N-RAS (1.10 ± 0.35 vs. 0.41 ± 0.36, t = 3.997, P = 0.012), p-AKT (1.16 ± 0.22 vs. 0.57 ± 0.03, t = 7.05, P = 0.001), and VEGF (0.97 ± 0.32 vs. 0.45 ± 0.21, t = 3.314, P = 0.008) in UM tumor tissues were significantly higher than those in normal uveal tissue. Luciferase assay demonstrated N-RAS and VEGF as downstream targets of miR-145. Moreover, tube formation assay revealed that miR-145-transfected human microvascular endothelial cell line formed shorter tube length (36.10 ± 1.51 mm vs. 42.91 ± 0.94 mm, t = 6.603, P = 0.003) and less branch points (350.00 ± 19.97 vs. 406.67 ± 17.62, t = 3.685, P = 0.021) as compared with controls. In addition, the numbers of invaded MUM-2B and OCM-1 cells with miR-145 overexpression were significantly lower than the controls (35.7 ± 3.3 vs. 279.1 ± 4.9, t = 273.75, P < 0.001 and 69.5 ± 4.4 vs. 95.6 ± 4.7, t = 21.27, P < 0.001, respectively). In vivo, xenografts expressing miR-145 had smaller sizes (miR-145 vs. miR-scr, 717.41 ± 502.62 mm3vs. 1694.80 ± 904.33 mm3, t = 2.314, P = 0.045) and lower weights (miR-145 vs. miR-scr, 0.74 ± 0.46 g vs. 1.65 ± 0.85 g, t = 2.295, P = 0.045).Conclusion:Our results indicated that miR-145 is an important tumor suppressor and the inhibitory strategies against N-RAS/VEGF signaling pathway might be potential therapeutic applications for UM in the future.

简介：AbstractBackground:High agglomeration of myeloid-derived suppressor cells (MDSCs) in neuroblastoma (NB) impeded therapeutic effects. This study aimed to investigate the role and mechanism of targeted inhibition of MDSCs by low-dose doxorubicin (DOX) to enhance immune efficacy in NB.Methods:Bagg albino (BALB/c) mice were used as tumor-bearing mouse models by injecting Neuro-2a cells, and MDSCs were eliminated by DOX or dopamine (DA) administration. Tumor-bearing mice were randomly divided into 2.5 mg/kg DOX, 5.0 mg/kg DOX, 50.0 mg/kg DA, and control groups (n = 20). The optimal drug and its concentration for MDSC inhibition were selected according to tumor inhibition. NB antigen-specific cytotoxic T cells (CTLs) were prepared. Tumor-bearing mice were randomly divided into DOX, CTL, anti-ganglioside (GD2), DOX+CTL, DOX+anti-GD2, and control groups. Following low-dose DOX administration, immunotherapy was applied. The levels of human leukocyte antigen (HLA)-I, CD8, interleukin (IL)-2 and interferon (IFN)-γ in peripheral blood, CTLs, T-helper 1 (Thl)/Th2 cytokines, perforin, granzyme and tumor growth were compared among the groups. The Wilcoxon two-sample test and repeated-measures analysis of variance were used to analyze results.Results:The slowest tumor growth (F = 6.095, P = 0.018) and strongest MDSC inhibition (F = 14.632, P = 0.001) were observed in 2.5 mg/kg DOX group. Proliferation of T cells was increased (F = 448.721, P < 0.001) and then decreased (F = 2.047, P = 0.186). After low-dose DOX administration, HLA-I (F = 222.489), CD8 (F = 271.686), Thl/Th2 cytokines, CD4+ and CD8+ lymphocytes, granzyme (F = 2376.475) and perforin (F = 488.531) in tumor, IL-2 (F = 62.951) and IFN-γ (F = 240.709) in peripheral blood of each immunotherapy group were all higher compared with the control group (all of P values < 0.05). The most significant increases in the aforementioned indexes and the most notable tumor growth inhibition were observed in DOX+anti-GD2 and DOX+CTL groups.Conclusions:Low-dose DOX can be used as a potent immunomodulatory agent that selectively impairs MDSC-induced immunosuppression, thereby fostering immune efficacy in NB.

简介：Thymoquinone(TQ),anactivecomponentderivedfromthemedialplantNigellasativa,hasbeenusedformedicalpurposesformorethan2000years.RecentstudieshavereportedthatTQblockedangiogenesisinanimalmodelandreducedmigration,adhesion,andinvasionofglioblastomacells.WehaverecentlyshownthatTQcouldexhibitapotentcytotoxiceffectandinduceapoptosisinmouseneuroblastoma(Neuro-2a)cells.Inthepresentstudy,TQtreatmentmarkedlydecreasedtheadhesionandmigrationofNeuro-2acells.TQdown-regulatedMMP-2andMMP-9proteinexpressionandmRNAlevelsandtheiractivities.Furthermore,TQsignificantlydown-regulatedtheproteinexpressionoftranscriptionfactorNF-κB(p65)butnotsignificantlyalteredtheexpressionofN-Myc.Takentogether,ourdataindicatedthatTQ'sinhibitoryeffectonthemigrationofNeuro-2acellswasmediatedthroughthesuppressionofMMP-2andMMP-9expression,suggestingthatTQtreatmentcanbeapromisingtherapeuticstrategyforhumanmalignantneuroblastoma.

简介：AbstractImportance:131I-metaiodobenzylguanidine (131I-mIBG) has a significant targeted antitumor effect for neuroblastoma. However, currently there is a paucity of data for the use of 131I-mIBG as a "front-line" therapeutic agent in those patients with newly diagnosed high-risk neuroblastoma as part of the conditioning regimen for myeloablative chemotherapy (MAC).Objective:To evaluate the feasibility of upfront consolidation treatment with 131I-mIBG plus MAC and hematopoietic stem cell transplantation (HSCT) in high-risk neuroblastoma patients.Methods:A retrospective, single-center study was conducted from 2003-2019 on newly diagnosed high-risk neuroblastoma patients without progressive disease (PD) after the completion of induction therapy. They received 131I-mIBG infusion and MAC followed by HSCT.Results:A total of 24 high-risk neuroblastoma patients were enrolled with a median age of 3.0 years at diagnosis. After receiving this sequential consolidation treatment, 3 of 13 patients who were in partial response (PR) before 131I-mIBG treatment achieved either complete response (CR) (n = 1) or very good partial response (VGPR) (n = 2) after HSCT. With a median follow-up duration of 13.0 months after 131I-mIBG therapy, the 5-year event-free survival and overall survival rates estimated were 29% and 38% for the entire cohort, and 53% and 67% for the patients who were in CR/VGPR at the time of 131I-mIBG treatment.Interpretation:Upfront consolidation treatment with 131I-mIBG plus MAC and HSCT is feasible and tolerable in high-risk neuroblastoma patients, however the survival benefit of this 131I-mIBG regimen is only observed in the patients who were in CR/VGPR at the time of 131I-mIBG treatment.

简介：AbstractBackground:Smell and taste loss are highly prevalent symptoms in coronavirus disease 2019 (COVID-19), although few studies have employed objective measures to quantify these symptoms, especially dysgeusia. Reports of unrecognized anosmia in COVID-19 patients suggests that self-reported measures are insufficient for capturing patients with chemosensory dysfunction.Objectives:The purpose of this study was to quantify the impact of recent COVID-19 infection on chemosensory function and demonstrate the use of at-home objective smell and taste testing in an at-risk population of healthcare workers.Methods:Two hundred and fifty healthcare workers were screened for possible loss of smell and taste using online surveys. Self-administered smell and taste tests were mailed to respondents meeting criteria for elevated risk of infection, and one-month follow-up surveys were completed.Results:Among subjects with prior SARS-CoV-2 infection, 73% reported symptoms of olfactory and/or gustatory dysfunction. Self-reported smell and taste loss were both strong predictors of COVID-19 positivity. Subjects with evidence of recent SARS-CoV-2 infection (<45 days) had significantly lower olfactory scores but equivalent gustatory scores compared to other subjects. There was a time-dependent increase in smell scores but not in taste scores among subjects with prior infection and chemosensory symptoms. The overall infection rate was 4.4%, with 2.5% reported by PCR swab.Conclusion:Healthcare workers with recent SARS-CoV-2 infection had reduced olfaction and normal gustation on self-administered objective testing compared to those without infection. Rates of infection and chemosensory symptoms in our cohort of healthcare workers reflect those of the general public.